Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 09 tags : Trial save search
Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer
Published: 2021-12-09 (Crawled : 00:00) - biospace.com/
IMUX | $1.27 4.96% 5.47% 280K
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
imu-935 prostate cancer trial phase 1 cancer enroll
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial
Published: 2021-12-09 (Crawled : 22:00) - biospace.com/
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 1.03%
H: 2.75%
C: -2.6%
sp-102 trial therapeutics opioid positive results phase 3 topline
STAG INDUSTRIAL TO PARTICIPATE IN TWO INDUSTRY CONFERENCES
Published: 2021-12-09 (Crawled : 21:00) - prnewswire.com
STAG | $34.38 -1.29% -0.09% 1.1M
|
Finance
|
| O: 0.43%
H: 1.59%
C: 0.91%
trial conference
Staley Point Capital Acquires Sylmar Industrial Property for $24 Million
Published: 2021-12-09 (Crawled : 21:00) - prnewswire.com
FNCTF | News | $11.0354 -0.83% -20.84% 0
|
Communications
|
| O: -0.39%
H: 0.05%
C: 0.05%
trial
Outlook Therapeutics to Present at the 14th Asia-Pacific Vitreo-Retina Society (APVRS) CongressSuber Huang, MD, MBA, FASRS will present data from the Phase 3 pivotal NORSE TWO registration trial
Published: 2021-12-09 (Crawled : 20:00) - biospace.com/
OTLK P | $8.29 -3.72% -3.92% 220K
|
Health Technology
|
| O: 6.0%
H: 1.57%
C: -6.29%
trial therapeutics retina phase 3
Repetitive transcranial magnetic stimulation in alcohol dependence: A randomized, double-blind, sham-controlled proof-of-concept trial targeting medial prefrontal and anterior cingulate cortex
Published: 2021-12-09 (Crawled : 19:00) - brainsway.com
BWAY | $4.79 -5.15% -5.21% 80K
|
Health Technology
|
| O: -4.0%
H: 0.0%
C: 0.0%
trial media
CytoDyn Submits Protocol with the FDA for Phase 3 Registrational Trial of Leronlimab for Critically Ill COVID-19 Population
Published: 2021-12-09 (Crawled : 19:00) - biospace.com/
CYDY | $0.1509 3.36% 0.06% 810K
|
Manufacturing
|
| O: 3.81%
H: 3.67%
C: -5.5%
covid-19 fda trial covid phase 3
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R. Program for Sciatica Pain Management Supporting the Potential Use of SP-102 as a Best-in-Class Therapy
Published: 2021-12-09 (Crawled : 17:00) - globenewswire.com
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 1.03%
H: 2.75%
C: -2.6%
sp-102 trial therapeutics potential opioid positive therapy results phase 3 topline
IO Biotech Announces Publication of Phase 1/2 Melanoma Clinical Trial Results in Nature Medicine
Published: 2021-12-09 (Crawled : 17:00) - globenewswire.com
IOBT | $1.47 -2.0% 1.95% 180K
|
|
| O: -2.3%
H: 0.95%
C: 0.0%
trial trial results phase 1 results biotech iot phase 2 phase 3
Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in Asia in Collaboration with BeiGene and Associated Milestone Payment
Published: 2021-12-09 (Crawled : 14:30) - biospace.com/
ZYME | $8.67 -2.03% -1.96% 730K
|
Health Technology
|
| O: -1.06%
H: 1.33%
C: -14.03%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 1.58%
H: 1.7%
C: -4.5%
expansion trial collaboration milestone
STMicroelectronics Drives the Future of EVs and Industrial Applications with New Silicon-Carbide Devices
Published: 2021-12-09 (Crawled : 14:30) - globenewswire.com
STMEF | $40.39 -5.77% 2.8K
|
Electronic Technology
|
| O: -0.26%
H: 0.0%
C: -2.81%
STM | $39.61 -1.79% -0.4% 3.1M
|
Electronic Technology
|
| O: -1.91%
H: 1.04%
C: -1.25%
electronics application device trial
Vir Biotechnology Announces Initiation of Phase 2 Clinical Trial Evaluating VIR-2218, Selgantolimod and Nivolumab for the Treatment of Chronic Hepatitis B Virus Infection
Published: 2021-12-09 (Crawled : 14:30) - biospace.com/
VIR | $7.96 -3.52% -3.64% 1.1M
|
Health Technology
|
| O: -1.69%
H: 6.48%
C: 2.62%
vir-2218 treatment phase 2 hepatitis technology trial biotech infection iot infections chronic hepatitis b nivolumab
NRx Pharmaceuticals and Hungarian Health Officials Agree on Pathway for ZYESAMI® and BriLife COVID-19 Vaccine Trials
Published: 2021-12-09 (Crawled : 14:30) - globenewswire.com
NRXP 1 d | $3.02 -27.75% -38.18% 760K
|
Manufacturing
|
| O: 0.67%
H: 5.85%
C: -3.34%
covid-19 zyesami health trials trial covid vaccine brilife
Essentium Adding Metal Additive Manufacturing Capabilities for Industrial-Scale Production
Published: 2021-12-09 (Crawled : 14:00) - prnewswire.com
ACAH | $10.45 0.0% 14K
|
|
| O: 0.3%
H: 0.1%
C: 0.1%
trial
BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects
Published: 2021-12-09 (Crawled : 13:00) - globenewswire.com
BWAY | $4.79 -5.15% -5.21% 80K
|
Health Technology
|
| O: 1.44%
H: 3.23%
C: 3.23%
trial trial results results
Industrial Wastewater Treatment Chemicals Market worth $16.6 billion by 2026 - Exclusive Report by MarketsandMarkets™
Published: 2021-12-09 (Crawled : 12:30) - prnewswire.com
ECL | $219.21 -0.02% 0.0% 920K
|
Process Industries
|
| O: -0.2%
H: 0.25%
C: -0.26%
DOW | News A | $56.49 -0.58% 0.0% 3.9M
|
Process Industries
|
| O: -1.92%
H: 0.63%
C: 0.28%
treatment trial
uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B
Published: 2021-12-09 (Crawled : 12:30) - globenewswire.com
QURE | $4.71 0.86% 0.85% 440K
|
Health Technology
|
| O: 5.19%
H: 1.33%
C: -6.6%
gene therapy trial therapy
Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application to Initiate a Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration
Published: 2021-12-09 (Crawled : 12:30) - globenewswire.com
OCGN | News A | $1.32 -8.33% -9.51% 7.7M
|
Health Technology
|
| O: 7.46%
H: 0.31%
C: -12.81%
ocu400 new drug fda application gene therapy drug trial fda acceptance phase 1 therapy retina
Greenwich LifeSciences Announces Presentation of 5 Year Data for GP2 Phase IIb Clinical Trial, Revealing Potential For New T Cell Platform Technology
Published: 2021-12-09 (Crawled : 12:30) - biospace.com/
GLSI | $12.89 -1.23% 0.53% 42K
|
Health Technology
|
| O: 4.11%
H: 0.9%
C: -12.42%
technology trial presentation potential platform t-cell
Industrial Ethernet Market Size to Grow by USD 29.39 Bn| Witnesses Emergence of ABB Ltd. and Analog Devices Inc. as Key Market Contributors | Technavio
Published: 2021-12-09 (Crawled : 09:00) - prnewswire.com
ABLZF | News | $45.744 -32.74% 1.5K
|
Producer Manufacturing
|
| O: -5.43%
H: 5.94%
C: 3.95%
BDC | News | $81.74 -0.72% 0.0% 170K
|
Producer Manufacturing
|
| O: -2.07%
H: 1.25%
C: -0.65%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 0.38%
H: 0.0%
C: 0.0%
device trial merge
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.